← Product Code [MEH](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/MEH) · K982032 # OSTEONICS OMNIFIT HA HIP STEM SERIES, OSTEONICS SECUR-FIT HA HIP STEM SERIES, OSTEONICS PRIMARY SECUR-FIT PLUS HIP STEMS (K982032) _Osteonics Corp. · MEH · Jul 9, 1998 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/MEH/K982032 ## Device Facts - **Applicant:** Osteonics Corp. - **Product Code:** [MEH](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/MEH.md) - **Decision Date:** Jul 9, 1998 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 888.3353 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use The Osteonics® C-Tapered Titanium Stems are single use components. They are intended for cementless fixation within the prepared femoral canals of patients requiring hip arthroplasty. The modified and predicate hip stems are intended to be used in conjunction with any commercially available Osteonics C-Taper femoral bearing head. For use as a total hip replacement, the modified and predicate stems may be used in conjunction with any legally marketed Osteonics acetabular component. The Osteonics® C-Tapered Titanium Stems are manufactured from titanium alloy (ASTM F-620-96). The indications for the Osteonics® C-Tapered Titanium Stems include the following: For Use as a Bipolar Hip Replacement: - Femoral head/neck fractures or non-unions. - Aseptic necrosis of the femoral head. - Osteo-, rheumatoid, and post-traumatic arthritis of the hip with minimal acetabular involvement or distortion. Other Considerations: - Pathological conditions or age considerations which indicate a more conservative acetabular procedure and an avoidance of the use of bone cement in the acetabulum. - Salvage of failed total hip arthroplasty. For Use as a Total Hip Replacement: - Painful, disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis or late stage avascular necrosis. - Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. - Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. ## Device Story Osteonics C-Tapered Titanium Stems are orthopedic implants for cementless femoral canal fixation during hip arthroplasty. Device modification involves shortening the trunnion and reducing stem neck diameter; all other design aspects remain identical to predicate devices. Implants are manufactured from titanium alloy (ASTM F-620-96). Used by orthopedic surgeons in clinical settings for total or bipolar hip replacement. Device provides mechanical interlock within the femoral canal; intended for use with Osteonics C-Taper femoral heads and acetabular components. Benefits include restoration of joint function in patients with disabling hip disease or fractures. Mechanical fatigue testing confirms substantial equivalence to predicate designs. ## Clinical Evidence Bench testing only. Mechanical fatigue testing was performed to demonstrate substantial equivalence in fatigue strength to predicate stem designs. ## Technological Characteristics Titanium alloy (ASTM F-620-96) hip prosthesis. Semi-constrained design for cementless fixation. Features a shortened trunnion and reduced neck diameter compared to previous versions. Mechanical interlock fixation principle. ## Regulatory Identification A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement. ## Predicate Devices - Osteonics® Omnifit® HA Hip Stem Series - Osteonics® Secur-Fit™ HA Hip Stem Series - Osteonics® Primary Secur-Fit™ Plus Hip Stem Series ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ JUL = 9 1998 K982032 # Special 510(k) - Device Modification Summary of Safety and Effectiveness for the Osteonics® C-Tapered Titanium Stems #### Submission Information Name and Address of the Sponsor of the 510(k) Submission: Contact Person: Osteonics Corporation 59 Route 17 Allendale, NJ 07401-1677 Kate Sutton Regulatory Affairs Specialist Date of Summary Preparation: June 9, 1998 Device Identification Proprietary Name: Common Name: Classification Name and Reference: Osteonics® Omnifit® HA Hip Stem Series Osteonics® Secur-Fit™ HA Hip Stem Series Osteonics® Primary Secur-Fit™ Plus Hip Stem Series Hip Prosthesis Hip Joint, Metal/Ceramic/Polymer, Semi-Constrained. Cemented or Non-Porous Uncemented Prosthesis 21 CFR §888.3353 #### Predicate Device Identification The modified features of the Osteonics® C-Tapered Titanium Stems (Osteonics® Omnifit HA Hip Stem Series, Osteonics® Secur-Fit HA Hip Stem Series® Primary Secur-Fit Plus HipStem Series) are substantially equivalent to features of the following Osteonics predicate devices, which has been cleared for marketing via the 510(k) process: - Osteonics® Omnifit® HA Hip Stem Series ● - Osteonics® Secur-Fit™ HA Hip Stem Series ● - Osteonics® Primary Secur-Fit™ Plus Hip Stem Series ● {1}------------------------------------------------ ### Device Description The Osteonics® C-Tapered Titanium Stems (Osteonics® Omnifit HA Hip Stem Series, Osteonics® Secur-Fit Hip Stem Series, Osteonics® Primary Secur-Fit Plus HipStem Series) are currently marketed devices that are being modification involves shortening the trunnion and reducing the diameter of the stem neck. All other aspects of the Osteonics® C-Tapered Titanium Stems will remain unchanged. ### Intended Use: The Osteonics® C-Tapered Titanium Stems are single use components. They are intended for cementless fixation within the prepared femoral canals of patients requiring hip arthroplasty. The modified and predicate hip stems are intended to be used in conjunction with any commercially available Osteonics C-Taper femoral bearing head. For use as a total hip replacement, the modified and predicate stems may be used in conjunction with any legally marketed Osteonics acetabular component. The Osteonics® C-Tapered Titanium Stems are manufactured from titanium alloy (ASTM F-620-96). The indications for the Osteonics® C-Tapered Titanium Stems include the following: For Use as a Bipolar Hip Replacement: - Femoral head/neck fractures or non-unions. . - Aseptic necrosis of the femoral head. - Osteo-, rheumatoid, and post-traumatic arthritis of the hip with minimal acetabular involvement . or distortion. Other Considerations: - Pathological conditions or age considerations which indicate a more conservative acetabular ● procedure and an avoidance of the use of bone cement in the acetabulum. - Salvage of failed total hip arthroplasty. For Use as a Total Hip Replacement: - . Painful, disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis or late stage avascular necrosis. - Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. - . Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. ### Performance Data: Mechanical testing has been performed to demonstrate the substantial equivalence of this Osteonics stem design to predicate stem designs in terms of its fatigue strength. {2}------------------------------------------------ ## Statement of Technological Comparison: All features of the Osteonics® C-Tapered Titanium Stems (Osteonics® Omnifit HA Hip Stem Series, Osteonics® Secur-Fit Hip Stem Series, Osteonics® Primary Secur-Fit Plus HipStem Series) will remain the same with the exception of the trunnion, which will be shortened, and the neck diameter, which will be slightly reduced. {3}------------------------------------------------ Image /page/3/Picture/12 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with three heads, representing health, human services, and science. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUL - 9 1998 Ms. Kate Sutton Requlatory Affairs Specialist Osteonics Corporation 59 Route 17 Allendale, New Jersey 07401-1677 Re: K982032 Osteonics® C-Tapered Titanium Stems Regulatory Class: II Product Code: MEH Dated: June 8, 1998 Received: June 10, 1998 Dear Ms. Sutton: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). This decision is based on consideration of the specific design of stem and coating composition detailed in this application. You may, therefore, market the device, subject to the general controls provisions of the Act and the following limitation: You may not label or in any way promote these devices for "biological attachment, enhanced clinical or radiographic performance, enhanced fixation and/or long-term stable fixation." The data presented support equivalence with no additional claims over a conventional press-fit.hip ____ prosthesis (i.e., mechanical interlock, only). Additional limitations for more specific claims of safety and effectiveness may be forthcoming. Should additional limitations be applied you will be contacted in writing to inform you of the additional labeling limitations. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. {4}------------------------------------------------ #### Page 2 - Ms. Kate Sutton You may market your device under the above limitations as class II devices. These devices would be considered not substantially equivalent to a legally marketed predicate device if labeled with other intended uses and/or claims of safety or effectiveness. Any other intended uses or claims may cause the device to be classified into Class III under Section 513 (f) of the Act. Class III devices are required to have an approved premarket approval (PMA) application prior to marketing. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800~to A substantially equivalent determination assumes 895. compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. In addition, FDA may publish further announcements concerning your device in the Federal Reqister. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal Laws or Regulations. This letter will allow you to beqin marketing your device as described in your 510(k) premarket notification immediately. An FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other qeneral information on your responsibilities under the Act may be {5}------------------------------------------------ Page 3 - Ms. Kate Sutton obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, C. Colby Mc. Whitney, Ph.D. Cella M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ 510(k) Number (if known): K982032 Device Name: Osteonics® C-Tapered Titanium Stems Indications For Use: The indications for the use of the Osteonics® C-Tapered Titanium Stems , in keeping with those of other legally marketed Osteonics femoral components, are as follows: For Use as a Bipolar Hip Replacement: - Femoral head/neck fractures or non-unions. . - Aseptic necrosis of the femoral head. - Osteo-, rheumatoid, and post-traumatic arthritis of the hip with minimal acetabular ● involvement or distortion. Other Considerations: - Pathological conditions or age considerations which indicate a more conservative acetabular ● procedure and an avoidance of the use of bone cement in the acetabulum. - . Salvage of failed total hip arthroplasty. For Use as a Total Hip Replacement: - Painful, disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid � arthritis, post-traumatic arthritis or late stage avascular necrosis. - Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. - Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of General Restorative Devices 510(k) Number K962032 Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/MEH/K982032](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/MEH/K982032) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com